Siegfried Holding Management
Management criteria checks 3/4
Siegfried Holding's CEO is Marcel Imwinkelried, appointed in Jan 2024, has a tenure of 1.08 years. total yearly compensation is CHF2.00M, comprised of 32.1% salary and 67.9% bonuses, including company stock and options. directly owns 0.012% of the company’s shares, worth CHF507.14K. The average tenure of the management team and the board of directors is 2.7 years and 4.8 years respectively.
Key information
Marcel Imwinkelried
Chief executive officer
CHF 2.0m
Total compensation
| CEO salary percentage | 32.1% |
| CEO tenure | 1.1yrs |
| CEO ownership | 0.01% |
| Management average tenure | 2.7yrs |
| Board average tenure | 4.8yrs |
Recent management updates
Recent updates
Siegfried Holding AG (VTX:SFZN) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Feb 21
Earnings Tell The Story For Siegfried Holding AG (VTX:SFZN)
Feb 19Siegfried Holding AG's (VTX:SFZN) Price In Tune With Earnings
Nov 09Is Siegfried Holding (VTX:SFZN) Using Too Much Debt?
Sep 12A Look At The Intrinsic Value Of Siegfried Holding AG (VTX:SFZN)
Aug 04Siegfried Holding AG (VTX:SFZN) Not Flying Under The Radar
Jun 17Siegfried Holding AG's (VTX:SFZN) CEO Compensation Looks Acceptable To Us And Here's Why
Apr 12Does Siegfried Holding (VTX:SFZN) Have A Healthy Balance Sheet?
Mar 15Earnings Miss: Siegfried Holding AG Missed EPS By 18% And Analysts Are Revising Their Forecasts
Feb 23CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2024 | CHF 2m | CHF 643k | CHF 160m |
Compensation vs Market: Marcel's total compensation ($USD2.23M) is about average for companies of similar size in the Swiss market ($USD2.12M).
Compensation vs Earnings: Insufficient data to compare Marcel's compensation with company performance.
CEO
Marcel Imwinkelried (57 yo)
1.1yrs
Tenure
CHF 2,002,862
Compensation
Mr. Marcel Imwinkelried serves as Chief Executive Officer at Siegfried Holding AG from 2024 and serves as its COO Drug Products ad interim since 2024 and was its Chief Operating Officer of Drug Products fr...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & COO Drug Products ad interim | 1.1yrs | CHF 2.00m | 0.012% CHF 507.1k | |
| Chief Financial Officer | 7.8yrs | no data | 0.35% CHF 15.2m | |
| Chief Scientific Officer | less than a year | no data | no data | |
| Chief Legal & Sustainability Officer | 6.1yrs | no data | no data | |
| Head of Corporate Communications | no data | no data | no data | |
| Chief Business Officer of Drug Substances & Drug Products | 4yrs | no data | 0.66% CHF 28.9m | |
| Head Global Quality Management DS - Zofingen | no data | no data | no data | |
| Head Regulatory Affairs - Site Zofingen | no data | no data | no data | |
| Head of Operations - Malta | no data | no data | no data | |
| Head Corporate Quality Systems - Global Quality Systems | no data | no data | no data | |
| Chief Operating Officer Drug Substances | 1.4yrs | no data | no data |
2.7yrs
Average Tenure
55yo
Average Age
Experienced Management: SFZN's management team is considered experienced (2.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Non-Executive Chairman | 14.8yrs | CHF 484.32k | 0.47% CHF 20.6m | |
| Independent Non-Executive Director | 4.8yrs | CHF 227.47k | 0.025% CHF 1.1m | |
| Independent Non-Executive Director | 11.1yrs | CHF 221.25k | 0.084% CHF 3.7m | |
| Independent Non-Executive Vice Chairman | 9.1yrs | CHF 253.79k | 0.061% CHF 2.7m | |
| Independent Director | 2.8yrs | CHF 222.20k | 0.012% CHF 523.2k | |
| Director | 1.8yrs | CHF 227.38k | 0.0081% CHF 352.7k | |
| Independent Director | 2.8yrs | CHF 216.94k | 0.012% CHF 523.2k |
4.8yrs
Average Tenure
56yo
Average Age
Experienced Board: SFZN's board of directors are considered experienced (4.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 11:39 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Siegfried Holding AG is covered by 23 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Thomas Meyer | Baader Helvea Equity Research |
| Volker Bosse | Baader Helvea Equity Research |
| Laura Lopez Pineda | Baader Helvea Equity Research |